BioSpace News Archive

Specialty Enzymes & Probiotics is proud to announce a clinical trial on the safety and efficacy of ImmunoSEB™ (systemic enzyme complex) and ProbioSEB CSC3™ (a spore-forming probiotic blend) in people experiencing Long COVID, specifically post-viral fatigue, was recently published in the peer-reviewed journal Medicines.

Debiopharm announced data releases on 3 investigational products including Debio 0123, clinical exploratory results for xevinapant, and 2 Multilink™ technology posters at the 2022 Annual American Association for Cancer Research meeting in New Orleans, Louisiana.

Pulse oximeters are gaining immense traction across the globe as more and more people around the world are considering self-health assessment tests at home, especially during and after the pandemic

IsoPlexis Corporation, the Superhuman Cell Company, announced its preliminary unaudited revenue for the first quarter of 2022 and the transition to an integrated commercial and operational structure, which is intended to ensure a sustainable growth path.

Syneos Health®, the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success, will release its first quarter 2022 financial results on Friday, April 29th, 2022, prior to its earnings call at 8:00 a.m. ET.